Fertility preservation in women with cervical, endometrial or ovarian cancers.

Gynecologic oncology research and practice Pub Date : 2016-07-27 eCollection Date: 2016-01-01 DOI:10.1186/s40661-016-0029-2
Michael Feichtinger, Kenny A Rodriguez-Wallberg
{"title":"Fertility preservation in women with cervical, endometrial or ovarian cancers.","authors":"Michael Feichtinger,&nbsp;Kenny A Rodriguez-Wallberg","doi":"10.1186/s40661-016-0029-2","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although cancer in general affects an aged population, a significant number of women develop cancer at childbearing age. Long-term survival rates after gynecological cancer, especially in young patients are increasing and all quality-of-life aspects, including preservation of fertility have become of major relevance.</p><p><strong>Outcomes: </strong>Surgical techniques aimed at sparing reproductive organs and preserving fertility have been developed for women presenting with gynecological cancer found at early stages. Indications for fertility-sparing surgery are in general restricted to women presenting with a well-differentiated low-grade tumor in its early stages or with low malignant potential. Up to now, use of fertility-sparing techniques in well-selected patients has not been shown to affect overall survival negatively and fertility outcomes reported have been favorable. Still larger amounts of data and longer follow-up periods are needed. Several current fertility-sparing cancer treatments may result in sub-fertility and in those cases assisted reproductive techniques are indicated. Overall quality of life has been satisfactory in cancer patients after fertility-sparing surgery.</p><p><strong>Conclusions: </strong>Fertility-sparing surgery is a viable tool to enable gynecological cancer patients of young age to fulfill their family building without impairment of oncological outcome. Cancer patients of reproductive age should undergo fertility counseling to analyze this sensitive subject. Further studies are needed to investigate the role of fertility-sparing treatment and combined adjuvant therapy in higher-grade cancers.</p>","PeriodicalId":91487,"journal":{"name":"Gynecologic oncology research and practice","volume":"3 ","pages":"8"},"PeriodicalIF":0.0000,"publicationDate":"2016-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40661-016-0029-2","citationCount":"41","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gynecologic oncology research and practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40661-016-0029-2","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2016/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 41

Abstract

Background: Although cancer in general affects an aged population, a significant number of women develop cancer at childbearing age. Long-term survival rates after gynecological cancer, especially in young patients are increasing and all quality-of-life aspects, including preservation of fertility have become of major relevance.

Outcomes: Surgical techniques aimed at sparing reproductive organs and preserving fertility have been developed for women presenting with gynecological cancer found at early stages. Indications for fertility-sparing surgery are in general restricted to women presenting with a well-differentiated low-grade tumor in its early stages or with low malignant potential. Up to now, use of fertility-sparing techniques in well-selected patients has not been shown to affect overall survival negatively and fertility outcomes reported have been favorable. Still larger amounts of data and longer follow-up periods are needed. Several current fertility-sparing cancer treatments may result in sub-fertility and in those cases assisted reproductive techniques are indicated. Overall quality of life has been satisfactory in cancer patients after fertility-sparing surgery.

Conclusions: Fertility-sparing surgery is a viable tool to enable gynecological cancer patients of young age to fulfill their family building without impairment of oncological outcome. Cancer patients of reproductive age should undergo fertility counseling to analyze this sensitive subject. Further studies are needed to investigate the role of fertility-sparing treatment and combined adjuvant therapy in higher-grade cancers.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
子宫颈癌、子宫内膜癌或卵巢癌患者的生育能力保存。
背景:虽然癌症通常影响老年人群,但相当多的妇女在育龄时患上癌症。妇科癌症后的长期生存率,特别是年轻患者的生存率正在增加,所有生活质量方面,包括生育能力的保存都变得重要。结果:针对早期发现妇科癌症的妇女,旨在保留生殖器官和保留生育能力的手术技术已经发展起来。保留生育能力手术的适应症一般限于早期表现为分化良好的低级别肿瘤或低恶性潜能的妇女。到目前为止,在精心挑选的患者中使用保留生育能力的技术尚未显示出对总体生存产生负面影响,并且报道的生育结果是有利的。还需要更大量的数据和更长的随访期。目前一些保留生育能力的癌症治疗可能导致生育能力低下,在这些情况下,辅助生殖技术是指。保留生育能力手术后癌症患者的总体生活质量令人满意。结论:保留生育能力的手术是一种可行的工具,可以使年轻妇科癌症患者在不损害肿瘤预后的情况下完成家庭建设。育龄癌症患者应接受生育咨询,以分析这一敏感话题。保留生育能力的治疗和联合辅助治疗在高级别癌症中的作用需要进一步的研究。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Extra-uterine low grade endometrioid stromal sarcoma arising from ovarian endometriosis: a case report and review of the literature. Preferences of women with epithelial ovarian cancer for aspects of genetic testing. Safety and feasibility of contained uterine morcellation in women undergoing laparoscopic hysterectomy. A small molecule inhibitor of the perinucleolar compartment, ML246, attenuates growth and spread of ovarian cancer. Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1